Prokidney (PROK) Net Cash Flow (2021 - 2026)

Prokidney (PROK) has reported Net Cash Flow for 6 consecutive years, with -$27.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Net Cash Flow fell 110.08% year-over-year to -$27.0 million in Q2 2026; TTM through Jun 2026 was -$10.1 million, a 92.23% increase from a year earlier, with the FY2025 full-year figure at $9.4 million, down 75.52% from the prior year.
• Net Cash Flow was -$27.0 million for Q2 2026 at Prokidney, down from -$6.6 million in the prior quarter.
• Over five years, Net Cash Flow peaked at $484.4 million in Q3 2022 and troughed at -$218.6 million in Q1 2023.
• A 5-year average of $3.0 million and a median of -$8.4 million in 2022 frame the typical range for Net Cash Flow.
• The widest YoY moves for Net Cash Flow: up 89230.89% in 2022, down 3749.36% in 2022.
• Over 5 years, Net Cash Flow stood at -$16.1 million in 2022, then slumped by 713.31% to -$130.7 million in 2023, then jumped by 93.14% to -$9.0 million in 2024, then jumped by 247.35% to $13.2 million in 2025, then tumbled by 304.53% to -$27.0 million in 2026.
• The last three Net Cash Flow figures came in at -$27.0 million (Q2 2026), -$6.6 million (Q1 2026), and $13.2 million (Q4 2025), per Business Quant data.